The Effect of a Race-Based Stress Reduction Intervention on Sleep Quality, Melatonin Onset, and Inflammation in African American Women: Protocol for a Pilot Randomized Controlled Trial

Mar 10, 2026Biological research for nursing

Race-Based Stress Reduction May Improve Sleep, Melatonin Timing, and Inflammation in African American Women

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

A pilot study will evaluate the effects of a race-based stress reduction intervention on sleep quality and melatonin levels in 32 older African American women at risk for cardiometabolic disease.

African American women face higher rates of cardiometabolic disease risk and sleep disturbances compared to other racial groups.
Sleep and melatonin are linked to inflammation, which is a key factor in cardiometabolic disease.
Chronic exposure to racism may disrupt sleep patterns and increase inflammatory responses.
The study will assess sleep quality using questionnaires and wrist-worn devices over seven nights.
Melatonin levels will be measured through salivary samples collected around bedtime.
Inflammation will be evaluated by measuring salivary cytokines pre- and post-intervention.

AI simplified

African American women carry a disproportionate burden of cardiometabolic disease (CMD) risk and experience higher rates of sleep disturbances compared to other racial and ethnic groups. Sleep and the sleep-regulating hormone melatonin play key roles in modulating inflammation, a biological pathway central to CMD. Chronic exposure to racism and discrimination may exacerbate stress, disrupt sleep and melatonin rhythms, and elevate inflammatory responses, further heightening CMD risk. The purpose of this pilot study is to evaluate the effects of a race-based stress reduction intervention-Resilience, Stress, and Ethnicity (RiSE)-on sleep quality and dim-light melatonin onset (DLMO) as primary outcomes, and to examine inflammation as a secondary outcome among older African American women with CMD risk. Leveraging an ongoing randomized controlled trial (RCT) (R01AG081251), this embedded pilot RCT will randomize 32 women to either the RiSE intervention or an attention control health education program, both delivered via eight weekly online sessions. Sleep quality will be assessed using validated questionnaires and wrist-worn ActiGraph devices for seven nights. DLMO will be determined from seven salivary samples collected around habitual bedtime, and salivary cytokines will be measured for inflammation. All measures will be obtained pre- and post-intervention. This pilot study is the first to examine an integrative, race-based stress reduction intervention targeting sleep and melatonin rhythms in this population. Findings will inform future mechanistic studies and the development of nurse-led strategies to mitigate the adverse physiological consequences of discrimination-related stress on sleep and cardiometabolic health among African American women.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (XML) ↗View full text ↗

The Effect of a Race-Based Stress Reduction Intervention on Sleep Quality, Melatonin Onset, and Inflammation in African American Women: Protocol for a Pilot Randomized Controlled Trial

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief